$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

$avrw Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000147793223005602 Filed on July 28, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue		$4.896M	$6.555M
YoY Change		-25.31%	219.6%
Cost Of Revenue		$1.557M	$2.173M
YoY Change		-28.35%	101.95%
Gross Profit		$3.339M	$4.382M
YoY Change		-23.8%	349.44%
Gross Profit Margin		68.2%	66.85%
Selling, General & Admin		$11.73M	$18.88M
YoY Change		-37.9%	66.12%
% of Gross Profit		351.15%	430.85%
Research & Development		$492.0K	$2.369M
YoY Change		-79.23%	-15.06%
% of Gross Profit		14.73%	54.06%
Depreciation & Amortization		$1.000K	$200.0K
YoY Change		-99.5%	0.0%
% of Gross Profit		0.03%	4.56%
Operating Expenses		$21.61M	$19.47M
YoY Change		10.96%	-2.3%
Operating Profit		-$18.27M	-$15.09M
YoY Change		21.06%	-20.39%
Interest Expense		$44.00K	$544.0K
YoY Change		-91.91%	-77.99%
% of Operating Profit
Other Income/Expense, Net		-$228.0K	$1.899M
YoY Change		-112.01%	-116.28%
Pretax Income		-$18.50M	-$13.19M
YoY Change		40.21%	-56.92%
Income Tax		$42.00K	$0.00
% Of Pretax Income
Net Earnings		-$25.51M	-$13.19M
YoY Change		93.35%	-56.92%
Net Earnings / Revenue		-521.02%	-201.27%
Basic Earnings Per Share			-$0.26
Diluted Earnings Per Share		-$0.36	-$0.26
COMMON SHARES
Basic Shares Outstanding	71.38M shares		50.18M shares
Diluted Shares Outstanding			50.18M shares

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.943M	$16.00K
YoY Change		18293.75%	-99.07%
Cash & Equivalents	$2.943M
Short-Term Investments
Other Short-Term Assets	$58.00K	$441.0K	$544.0K
YoY Change	-56.06%	-18.93%	-62.53%
Inventory	$145.0K	$145.0K	$864.0K
Prepaid Expenses	$176.0K
Receivables	$232.0K	$232.0K	$357.0K
Other Receivables		$2.167M	$0.00
Total Short-Term Assets	$5.928M	$5.928M	$1.781M
YoY Change	232.85%	232.85%	-53.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.000K	$164.0K	$2.138M
YoY Change	-99.78%	-92.33%	-13.41%
Goodwill	$0.00
YoY Change	-100.0%
Intangibles	$244.0K
YoY Change	-98.34%
Long-Term Investments		$411.0K	$216.0K
YoY Change		90.28%	-57.56%
Other Assets		$36.00K	$83.00K
YoY Change		-56.63%	43.1%
Total Long-Term Assets	$926.0K	$926.0K	$38.79M
YoY Change	-97.61%	-97.61%	-8.74%
TOTAL ASSETS
Total Short-Term Assets	$5.928M	$5.928M	$1.781M
Total Long-Term Assets	$926.0K	$926.0K	$38.79M
Total Assets	$6.854M	$6.854M	$40.57M
YoY Change	-83.11%	-83.11%	-12.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.065M	$1.065M	$2.848M
YoY Change	-62.61%	-62.61%	33.4%
Accrued Expenses	$1.585M	$1.709M	$3.857M
YoY Change	-57.77%	-55.69%	177.08%
Deferred Revenue
YoY Change
Short-Term Debt		$711.0K	$3.662M
YoY Change		-80.58%	64.95%
Long-Term Debt Due		$9.180M	$11.96M
YoY Change		-23.22%	54.75%
Total Short-Term Liabilities	$13.91M	$13.91M	$24.26M
YoY Change	-42.65%	-42.65%	67.7%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$27.00K
YoY Change		-100.0%	-99.62%
Other Long-Term Liabilities		$46.00K	$174.0K
YoY Change		-73.56%	-95.12%
Total Long-Term Liabilities		$46.00K	$201.0K
YoY Change		-77.11%	-98.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.91M	$13.91M	$24.26M
Total Long-Term Liabilities		$46.00K	$201.0K
Total Liabilities	$13.96M	$13.96M	$24.46M
YoY Change	-42.94%	-42.94%	-2.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$120.0M
YoY Change	27.01%
Common Stock	$71.00K
YoY Change	2.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.105M	-$7.105M	$16.11M
YoY Change
Total Liabilities & Shareholders Equity	$6.854M	$6.854M	$40.57M
YoY Change	-83.11%	-83.11%	-12.48%

Cashflow Statement

Concept	2022	2021
OPERATING ACTIVITIES
Net Income	-$25.51M	-$13.19M
YoY Change	93.35%	-56.92%
Depreciation, Depletion And Amortization	$1.000K	$200.0K
YoY Change	-99.5%	0.0%
Cash From Operating Activities	-$10.07M	-$4.315M
YoY Change	133.44%	-55.62%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	$35.00K
YoY Change	-97.14%	-94.8%
Acquisitions
YoY Change
Other Investing Activities	$13.84M	-$57.00K
YoY Change	-24375.44%	-110.23%
Cash From Investing Activities	$13.84M	-$175.0K
YoY Change	-8006.86%	33.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$837.0K	$2.781M
YoY Change	-130.1%	-62.83%
NET CHANGE
Cash From Operating Activities	-$10.07M	-$4.315M
Cash From Investing Activities	$13.84M	-$175.0K
Cash From Financing Activities	-$837.0K	$2.781M
Net Change In Cash	$2.927M	-$1.709M
YoY Change	-271.27%	-27.92%
FREE CASH FLOW
Cash From Operating Activities	-$10.07M	-$4.315M
Capital Expenditures	$1.000K	$35.00K
Free Cash Flow	-$10.07M	-$4.350M
YoY Change	131.59%	-58.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441000	usd
CY2021Q4	us-gaap	Investments Investments	216000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	4690000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	261000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	244000	usd
CY2022Q4	us-gaap	Assets Assets	6854000	usd
CY2021Q4	us-gaap	Assets Assets	40574000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1065000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2848000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	24462000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	69000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110146000	usd
CY2021Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	343000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-94446000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40574000	usd
CY2022Q4	curr	Customer Relationships Trade Name And Non Compete Agreements Net CustomerRelationshipsTradeNameAndNonCompeteAgreementsNet	71000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	36000	usd
CY2022Q4	curr	Long Term Assets Held For Sale LongTermAssetsHeldForSale	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	124000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	161000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q4	curr	Fair Value Convertible Promissory Notes Net FairValueConvertiblePromissoryNotesNet	9180000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	860000	usd
CY2022Q4	curr	Current Liabilities Held For Sale CurrentLiabilitiesHeldForSale	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13913000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13959000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	112471000	usd
CY2022Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	308000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119955000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7105000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6854000	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001643301
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71426801	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68201900	shares
CY2021	curr	Contract Liabilities Ending Balance ContractLiabilitiesEndingBalance	293000	usd
CY2021	curr	Vested Stock Options From The Companys2017 Equity Incentive Plan VestedStockOptionsFromTheCompanys2017EquityIncentivePlan	4067452	shares
CY2022	curr	Vested Stock Options From The Companys2017 Equity Incentive Plan VestedStockOptionsFromTheCompanys2017EquityIncentivePlan	1107980	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2021	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-204857
CY2022	dei	Entity Registrant Name EntityRegistrantName	AVENIR WELLNESS SOLUTIONS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1504639
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	5805 Sepulveda Boulevard
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 801
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Sherman Oaks
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91411
CY2022	dei	City Area Code CityAreaCode	424
CY2022	dei	Local Phone Number LocalPhoneNumber	273-8675
CY2022	dei	Security12g Title Security12gTitle	Common stock, par value $0.001
CY2022	dei	Trading Symbol TradingSymbol	CURR
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	12400000	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71704091	shares
CY2022	dei	Auditor Name AuditorName	RBSM LLP
CY2022	dei	Auditor Location AuditorLocation	Las Vegas, NV
CY2022	dei	Auditor Firm AuditorFirmId	587
CY2022Q4	curr	Due From Related Party DueFromRelatedParty	167	usd
CY2021Q4	curr	Due From Related Party DueFromRelatedParty	0	usd
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	2000000	usd
CY2021Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	0	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	145000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	710000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	358000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	340000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	200000	usd
CY2022Q4	us-gaap	Investments Investments	411000	usd
CY2021Q4	curr	Customer Relationships Trade Name And Non Compete Agreements Net CustomerRelationshipsTradeNameAndNonCompeteAgreementsNet	7297000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	48000	usd
CY2021Q4	curr	Long Term Assets Held For Sale LongTermAssetsHeldForSale	25820000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1585000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3485000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	104000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	235000	usd
CY2022Q4	curr	Related Party Payable RelatedPartyPayable	0	usd
CY2021Q4	curr	Related Party Payable RelatedPartyPayable	2011000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2877000	usd
CY2021Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2021Q4	curr	Fair Value Convertible Promissory Notes Net FairValueConvertiblePromissoryNotesNet	9932000	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	388000	usd
CY2021Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	293000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1430000	usd
CY2021Q4	curr	Current Liabilities Held For Sale CurrentLiabilitiesHeldForSale	496000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24261000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174000	usd
CY2022Q4	curr	Long Term Liabilities Held For Sale LongTermLiabilitiesHeldForSale	0	usd
CY2021Q4	curr	Long Term Liabilities Held For Sale LongTermLiabilitiesHeldForSale	27000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71426801	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68201900	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16112000	usd
CY2022	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	4896000	usd
CY2021	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	5715000	usd
CY2022	curr	Ppe Sales PpeSales	0	usd
CY2021	curr	Ppe Sales PpeSales	363000	usd
CY2022	us-gaap	Revenues Revenues	4896000	usd
CY2021	us-gaap	Revenues Revenues	6078000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1557000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1749000	usd
CY2022	us-gaap	Gross Profit GrossProfit	3339000	usd
CY2021	us-gaap	Gross Profit GrossProfit	4329000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11725000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16496000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4690000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	5764000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-570000	usd
CY2021	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-1775000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	21609000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	14721000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-18270000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10392000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	51000	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	62000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	73000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	2434000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	90000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	741000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-17000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41000	usd
CY2022	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	85000	usd
CY2021	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-393000	usd
CY2022	curr	Reserve On Investment ReserveOnInvestment	-71000	usd
CY2021	curr	Reserve On Investment ReserveOnInvestment	-350000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	465000	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	640000	usd
CY2022	us-gaap	Other Income OtherIncome	26000	usd
CY2021	us-gaap	Other Income OtherIncome	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-228000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1813000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18498000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8579000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-18540000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8579000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-6404000	usd
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-4614000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-565000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
CY2021	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-6969000	usd
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-4614000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25509000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-13193000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.26
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.10
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.07
CY2022	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.36
CY2021	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.21
CY2022	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	70205544	shares
CY2021	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	62350339	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	21279000	usd
CY2021	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	787000	usd
CY2021	curr	Issuance Of Common Stock From The Equity Incentive Plan Amount IssuanceOfCommonStockFromTheEquityIncentivePlanAmount	-50000	usd
CY2021	curr	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants	0	usd
CY2021	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	4146000	usd
CY2021	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	2571000	usd
CY2021	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	572000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-13193000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16112000	usd
CY2022	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	38000	usd
CY2022	curr	Issuance Of Common Stock Pursuant To Vested Restricted Stock Units Amount IssuanceOfCommonStockPursuantToVestedRestrictedStockUnitsAmount	0	usd
CY2022	curr	Issuance Of Restricted Stock Amount IssuanceOfRestrictedStockAmount	216000	usd
CY2022	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	420000	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	952000	usd
CY2022	curr	Issuance Of Common Stock For Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockForConversionOfConvertiblePromissoryNotesAmount	666000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25509000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7105000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-18540000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8579000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6969000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4614000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25509000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-13193000	usd
CY2022	curr	Loss On Disposal Of Pharmaceutical Assets And Liabilities LossOnDisposalOfPharmaceuticalAssetsAndLiabilities	565000	usd
CY2021	curr	Loss On Disposal Of Pharmaceutical Assets And Liabilities LossOnDisposalOfPharmaceuticalAssetsAndLiabilities	0	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7000	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	787000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	50000	usd
CY2022	curr	Gain From Settlement Of Accounts Payable GainFromSettlementOfAccountsPayable	83000	usd
CY2021	curr	Gain From Settlement Of Accounts Payable GainFromSettlementOfAccountsPayable	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	90000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	741000	usd
CY2022	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-570000	usd
CY2021	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-1775000	usd
CY2022	curr	Gain Loss In Fair Value Of Convertible Promissory Notes GainLossInFairValueOfConvertiblePromissoryNotes	85000	usd
CY2021	curr	Gain Loss In Fair Value Of Convertible Promissory Notes GainLossInFairValueOfConvertiblePromissoryNotes	-393000	usd
CY2022	curr	Reserve On Investment ReserveOnInvestment	-71000	usd
CY2021	curr	Reserve On Investment ReserveOnInvestment	-350000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1481000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2327000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4690000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	5764000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	97000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	86000	usd
CY2022	curr	Bad Debt Expenses BadDebtExpenses	0	usd
CY2021	curr	Bad Debt Expenses BadDebtExpenses	41000	usd
CY2022	curr	Recovery Of Bad Debt Expense RecoveryOfBadDebtExpense	-35000	usd
CY2021	curr	Recovery Of Bad Debt Expense RecoveryOfBadDebtExpense	-221000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	253000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	109000	usd
CY2022	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	-1619000	usd
CY2021	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	-3143000	usd
CY2022	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	33	usd
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-160000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	174000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-312000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	579000	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-167	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	96000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-926000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	69000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	25000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1661000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	719000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1858000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2884000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-108000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-93000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	95000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-701000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-5111000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-1472000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10073000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4315000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	53000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	57000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	13891000	usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
CY2022	curr	Payments To Acquire Long Term Assets Held For Sale PaymentsToAcquireLongTermAssetsHeldForSale	0	usd
CY2021	curr	Payments To Acquire Long Term Assets Held For Sale PaymentsToAcquireLongTermAssetsHeldForSale	118000	usd
CY2022	curr	Payments To Acquire Note Receivable PaymentsToAcquireNoteReceivable	0	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2243000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2021	curr	Payments To Acquire Note Receivable PaymentsToAcquireNoteReceivable	200000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	0	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	200000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13837000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-175000	usd
CY2022	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	3702000	usd
CY2021	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	415000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3935000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1600000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6347000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	190000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	796000	usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	161000	usd
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	279000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	235000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	309000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-837000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2781000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2927000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1709000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1725000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2943000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	585000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	102000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	666000	usd
CY2021	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	4146000	usd
CY2022	curr	Repayment Of Buyer Advances RepaymentOfBuyerAdvances	-4150000	usd
CY2021	curr	Repayment Of Buyer Advances RepaymentOfBuyerAdvances	0	usd
CY2022	curr	Common Stock Received For Conversion Of Note Receivable CommonStockReceivedForConversionOfNoteReceivable	213000	usd
CY2021	curr	Common Stock Received For Conversion Of Note Receivable CommonStockReceivedForConversionOfNoteReceivable	0	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	42000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
CY2022Q4	curr	Working Capital Deficit WorkingCapitalDeficit	-7900000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Significant areas requiring the use of management estimates include, but are not limited to, the allowance for doubtful accounts, valuation of intangible assets and goodwill, depreciative and amortization useful lives, assumptions used to calculate the fair value of the contingent stock consideration, stock based compensation, beneficial conversion features, warrant values, valuation allowance on deferred taxes, incremental borrowing rate (“IBR”) relating to leases, assumption used for discounts and returns in relation to revenue and the assumptions used to calculate derivative liabilities and fair values of the purchase price allocations and convertible promissory notes. Actual results could differ materially from such estimates under different assumptions or circumstances. </p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	80000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4700000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	curr	Imapirment Loss On Goodwill From Discontinued Operations ImapirmentLossOnGoodwillFromDiscontinuedOperations	4700000	usd
CY2021	curr	Imapirment Loss On Goodwill From Discontinued Operations ImapirmentLossOnGoodwillFromDiscontinuedOperations	0	usd
CY2022	curr	Impairment Loss On Intangibles Assets ImpairmentLossOnIntangiblesAssets	5800000	usd
CY2021	curr	Impairment Loss On Intangibles Assets ImpairmentLossOnIntangiblesAssets	0	usd
CY2021	curr	Contract Liabilities Beginning Balance ContractLiabilitiesBeginningBalance	994000	usd
CY2021	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	435000	usd
CY2021	curr	Customer Deposits Returned CustomerDepositsReturned	-713000	usd
CY2021	curr	Transfers To Revenue TransfersToRevenue	-208000	usd
CY2021	curr	Contract Liabilities Held For Sale ContractLiabilitiesHeldForSale	-215000	usd
CY2022	curr	Contract Liabilities Beginning Balance ContractLiabilitiesBeginningBalance	293000	usd
CY2022	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	48000	usd
CY2022	curr	Customer Deposits Returned CustomerDepositsReturned	0	usd
CY2022	curr	Transfers To Revenue TransfersToRevenue	-146000	usd
CY2022	curr	Contract Liabilities Not Transferred ContractLiabilitiesNotTransferred	193000	usd
CY2022	curr	Contract Liabilities Ending Balance ContractLiabilitiesEndingBalance	388000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2200000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2900000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	492000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2400000	usd
CY2022Q4	curr	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
CY2022Q4	curr	Value Of Stock Earn Out Payment In Clawback Period ValueOfStockEarnOutPaymentInClawbackPeriod	0	usd
CY2022	curr	Clawback Expected Gross Profit ClawbackExpectedGrossProfit	8000000.0	usd
CY2022Q4	curr	Earn Out Stock Value EarnOutStockValue	1000000.0	usd
CY2022Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	860000	usd
CY2022Q4	curr	Fair Value Of Series A Note FairValueOfSeriesANote	5221000	usd
CY2022Q4	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	3959000	usd
CY2021Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	1430000	usd
CY2021Q4	curr	Fair Value Of Series A Note FairValueOfSeriesANote	3075000	usd
CY2021Q4	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	6857000	usd
CY2020Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	13684000	usd
CY2021	curr	Changes In Fair Value Of Series A Note ChangesInFairValueOfSeriesANote	-1054000	usd
CY2021	curr	Change In Fair Value Of Series B Notes ChangeInFairValueOfSeriesBNotes	1448000	usd
CY2021	curr	Conversion Of Series A Notes ConversionOfSeriesANotes	-2881000	usd
CY2021	curr	Conversion Of Series B Notes ConversionOfSeriesBNotes	-1265000	usd
CY2021Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9932000	usd
CY2022	curr	Changes In Fair Value Of Series A Note ChangesInFairValueOfSeriesANote	-2146000	usd
CY2022	curr	Change In Fair Value Of Series B Notes ChangeInFairValueOfSeriesBNotes	-2232000	usd
CY2022	curr	Conversion Of Series B Notes ConversionOfSeriesBNotes	-666000	usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9180000	usd
CY2022	curr	Stock Price StockPrice	0.25
CY2021	curr	Stock Price StockPrice	0.36
CY2022	curr	Conversion Price ConversionPrice	1.32
CY2021	curr	Conversion Price ConversionPrice	1.32
CY2022	curr	Interest Rate InterestRate	0.180	pure
CY2021	curr	Interest Rate InterestRate	0.180	pure
CY2022	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	85000	usd
CY2021	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	-394000	usd
CY2022	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company determines the accounting classification of warrants it issues, as either liability or equity classified, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity," then in accordance with ASC 815-40, "Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock." Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the Company to settle the warrants or the underlying shares by paying cash or other assets, or warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, and in order to conclude equity classification, the Company also assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP. After all relevant assessments, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date. The Company does not have any liability classified warrants as of any period presented.</p>
CY2022	curr	Warrants Shares WarrantsShares	312500	shares
CY2021	curr	Warrants Shares WarrantsShares	1565447	shares
CY2022	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	416667	shares
CY2021	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	115047	shares
CY2022	curr	Total Anti Dilutive Shares TotalAntiDilutiveShares	1837147	shares
CY2021	curr	Total Anti Dilutive Shares TotalAntiDilutiveShares	5747946	shares
CY2022	curr	Common Stock Conversion Price CommonStockConversionPrice	1.32
CY2022	curr	Correction Of Error Weighted Average And Earning Per Share CorrectionOfErrorWeightedAverageAndEarningPerShare	Company became aware of an error in the calculation of its weighted average common shares outstanding and resultant reported loss per share for the year ended December 31, 2021. The reported weighted average common shares outstanding and loss per share was 50,182,299 and ($0.26), respectively. The corrected weighted shares outstanding and loss per share was 62,350,339 and ($0.21), respectively
CY2022Q4	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	232000	usd
CY2021Q4	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	437000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	80000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	232000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	357000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	207000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	302000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	176000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10000	usd
CY2022Q4	curr	Prepaid Media Advertising PrepaidMediaAdvertising	29000	usd
CY2021Q4	curr	Prepaid Media Advertising PrepaidMediaAdvertising	0	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	29000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	46000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	358000	usd
CY2022Q4	curr	Inventory Packaging Components InventoryPackagingComponents	88000	usd
CY2021Q4	curr	Inventory Packaging Components InventoryPackagingComponents	325000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	420000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	494000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	508000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	819000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	-363000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	-109000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	145000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	710000	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	359000	usd
CY2021	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	27000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	4000	usd
CY2021Q4	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	3000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2022	us-gaap	Depreciation Depreciation	1000	usd
CY2021	us-gaap	Depreciation Depreciation	1000	usd
CY2022Q4	curr	Current Portion Of Note Receivable CurrentPortionOfNoteReceivable	-2000000	usd
CY2021Q4	curr	Current Portion Of Note Receivable CurrentPortionOfNoteReceivable	0	usd
CY2022Q4	curr	Notes Receivable Net Of Current Portion NotesReceivableNetOfCurrentPortion	0	usd
CY2021Q4	curr	Notes Receivable Net Of Current Portion NotesReceivableNetOfCurrentPortion	200000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	0	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	4690000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	90000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10182000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-19000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2885000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	71000	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	7297000	usd
CY2022Q2	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	4600000	usd
CY2022	curr	Other Asset Impairments Charges OtherAssetImpairmentsCharges	4700000	usd
CY2021	curr	Other Asset Impairments Charges OtherAssetImpairmentsCharges	1100000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10400000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	56000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	43000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	23000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	19000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	17	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	157	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	315000	usd
CY2022Q4	curr	Investment In Biopharmaceutical Research Company InvestmentInBiopharmaceuticalResearchCompany	213000	usd
CY2021Q4	curr	Investment In Biopharmaceutical Research Company InvestmentInBiopharmaceuticalResearchCompany	0	usd
CY2022Q4	curr	Investment Net InvestmentNet	411000	usd
CY2021Q4	curr	Investment Net InvestmentNet	216000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	421000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	350000	usd
CY2022Q4	curr	Accounts Payable Factoring AccountsPayableFactoring	0	usd
CY2021Q4	curr	Accounts Payable Factoring AccountsPayableFactoring	1722000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	551000	usd
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	445000	usd
CY2022Q4	curr	Accrued Interest AccruedInterest	233000	usd
CY2021Q4	curr	Accrued Interest AccruedInterest	390000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	82000	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	178000	usd
CY2022Q4	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	64000	usd
CY2021Q4	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	173000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	324000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	243000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	331000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	334000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1585000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3485000	usd
CY2022Q4	curr	Accrued Liabilities For Related Parties AccruedLiabilitiesForRelatedParties	0	usd
CY2021Q4	curr	Accrued Liabilities For Related Parties AccruedLiabilitiesForRelatedParties	83000	usd
CY2022	curr	Interest Expenses For Related Parties InterestExpensesForRelatedParties	111000	usd
CY2021	curr	Interest Expenses For Related Parties InterestExpensesForRelatedParties	127000	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	161000	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	235000	usd
CY2022Q4	curr	Loans Payable Non Current LoansPayableNonCurrent	0	usd
CY2021Q4	curr	Loans Payable Non Current LoansPayableNonCurrent	0	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2877000	usd
CY2022Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2021Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2022	us-gaap	Interest Expense InterestExpense	44000	usd
CY2021	us-gaap	Interest Expense InterestExpense	44000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	5221000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	3074000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	3959000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	11858	usd
CY2022Q4	us-gaap	Commercial Paper CommercialPaper	9180000	usd
CY2021Q4	us-gaap	Commercial Paper CommercialPaper	14932000	usd
CY2022Q4	curr	Less Investor Note Offset LessInvestorNoteOffset	0	usd
CY2021Q4	curr	Less Investor Note Offset LessInvestorNoteOffset	-5000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9180000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9932000	usd
CY2022Q4	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-9180000	usd
CY2021Q4	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-9932000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2022	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	In addition, the placement agent received a warrant (the “Warrant”) exercisable for two years for the purchase of an aggregate of up to 242,424 shares of the Company’s common stock, at an exercise price of $1.32 per share. The Warrant may also be exercised by means of a “cashless exercise” or “net exercise.” Upon the achievement of certain milestones, the placement agent is entitled to receive an additional warrant, on the same terms as the Warrant, exercisable for an aggregate of up to 363,636 shares of the Company’s common stock (collectively with the shares underlying the Warrant, the “Warrant Shares”). The Warrant Shares, when issued, will have the same rights
CY2022	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.18	pure
CY2020Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.32
CY2020Q4	curr	Warranty Exercise Price Per Share WarrantyExercisePricePerShare	1.32
CY2022	us-gaap	Debt Conversion Description DebtConversionDescription	The Investor will not have the right to convert any portion of a Convertible Notes, to the extent that, after giving effect to such conversion, the Investor (and other certain related parties) would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect to such conversion. This limit may, from time to time, be increased, up to 9.99%, or decreased
CY2022	curr	Remaining Balance Of Investor Note RemainingBalanceOfInvestorNote	6400000	usd
CY2022	curr	Warrant Exercisable Shares WarrantExercisableShares	3751392	shares
CY2022	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	6100000	usd
CY2022Q4	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Bc ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBC	312500	shares
CY2022	curr	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P1Y1M13D
CY2022	curr	Number Of Warrants Exercisable Weighted Average Exercise Price NumberOfWarrantsExercisableWeightedAverageExercisePrice	2.00
CY2022	curr	Number Of Warrants Exercisable NumberOfWarrantsExercisable	312500	usd
CY2022	curr	Weighted Average Exercise Price WeightedAverageExercisePrice	2.00
CY2021Q4	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Bc ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBC	1565447	shares
CY2021	curr	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P0Y7M28D
CY2021	curr	Number Of Warrants Exercisable Weighted Average Exercise Price NumberOfWarrantsExercisableWeightedAverageExercisePrice	2.18
CY2021	curr	Number Of Warrants Exercisable NumberOfWarrantsExercisable	1565447	usd
CY2021	curr	Weighted Average Exercise Price WeightedAverageExercisePrice	2.18
CY2022	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
CY2022	curr	Term Of Exercise Period TermOfExercisePeriod	P10Y
CY2022	curr	Share Based Compensation Arrangement By Share Based Payment Number Of Awards Outstanding ShareBasedCompensationArrangementByShareBasedPaymentNumberOfAwardsOutstanding	3169939	shares
CY2022	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Remaining Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageRemainingContractualLifeYears	P8Y18D
CY2022	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageExercisePrice	1.20
CY2022	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	1107980	shares
CY2022	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Exercise Price Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageExercisePriceExercisable	1.39
CY2021	curr	Share Based Compensation Arrangement By Share Based Payment Number Of Awards Outstanding ShareBasedCompensationArrangementByShareBasedPaymentNumberOfAwardsOutstanding	7230068	shares
CY2021	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Remaining Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageRemainingContractualLifeYears	P8Y3M7D
CY2021	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageExercisePrice	1.45
CY2021	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	4067452	shares
CY2021	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Exercise Price Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageExercisePriceExercisable	1.51
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	80000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1500000	shares
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1000000.0	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2000000.0	usd
CY2022	curr	Unrecognized Compensation Expense UnrecognizedCompensationExpense	328000	usd
CY2022	curr	Weighted Average Remaining Contractual Life Year WeightedAverageRemainingContractualLifeYear	P1Y2M26D
CY2022	curr	Schedule Of Nonvested Restricted Award Shares ScheduleOfNonvestedRestrictedAwardShares	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Restricted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stock </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-vested, December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.60</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">338,443</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(388,443 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-vested, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">971,664</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(971,664 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-vested, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	curr	Marginal Tax Rate MarginalTaxRate	0.21	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	35100000	usd
CY2022	curr	Net Operating Loss Carryforward Expire NetOperatingLossCarryforwardExpire	6500000	usd
CY2022	curr	Net Operating Loss Carryforwards Expiration Date NetOperatingLossCarryforwardsExpirationDate	2038
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	28600000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	39000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7581000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6862000	usd
CY2022Q4	curr	Changes In Fair Value Of Convertible Promissory Notes ChangesInFairValueOfConvertiblePromissoryNotes	1358000	usd
CY2021Q4	curr	Changes In Fair Value Of Convertible Promissory Notes ChangesInFairValueOfConvertiblePromissoryNotes	2517000	usd
CY2022Q4	us-gaap	Deferred Compensation Cash Based Arrangements Liability Current DeferredCompensationCashBasedArrangementsLiabilityCurrent	1181000	usd
CY2021Q4	us-gaap	Deferred Compensation Cash Based Arrangements Liability Current DeferredCompensationCashBasedArrangementsLiabilityCurrent	899000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	114000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	142000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	98000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	74000	usd
CY2022Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	3000	usd
CY2021Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	89000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	423000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	195000	usd
CY2022Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	124000	usd
CY2021Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	31000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	94000	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	79000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	22000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	116000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	135000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	10246000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	11045000	usd
CY2022Q4	curr	Deferred Income Tax Liabilities State Income Taxes DeferredIncomeTaxLiabilitiesStateIncomeTaxes	0	usd
CY2021Q4	curr	Deferred Income Tax Liabilities State Income Taxes DeferredIncomeTaxLiabilitiesStateIncomeTaxes	0	usd
CY2022Q4	curr	Right Of Use Assets RightOfUseAssets	0	usd
CY2021Q4	curr	Right Of Use Assets RightOfUseAssets	-83000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	172000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	43000	usd
CY2022Q4	curr	Deferred Income Tax Liabilities Depreciation And Amortization DeferredIncomeTaxLiabilitiesDepreciationAndAmortization	-19000	usd
CY2021Q4	curr	Deferred Income Tax Liabilities Depreciation And Amortization DeferredIncomeTaxLiabilitiesDepreciationAndAmortization	-48000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10055000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10871000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	10196000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11045000	usd
CY2022Q4	curr	Deferred Income Tax Net DeferredIncomeTaxNet	0	usd
CY2021Q4	curr	Deferred Income Tax Net DeferredIncomeTaxNet	0	usd
CY2022Q4	curr	Ownership Interest OwnershipInterest	0.50	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	1	pure
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	816000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7800000	usd
CY2022	curr	Description Of Lease Agreement DescriptionOfLeaseAgreement	The lease agreement (the “Lease”) which expires on April 30, 2024 contains an option to extend the lease for an additional 36 months and the Company will reassess the lease term of the contract when it has determined it is reasonably certain to exercise the option. The lease provides for the payment of base monthly rent in the amount of $10 thousand during the first 12 months of the term with annual increases, over the base monthly rent then in effect, by 3%.
CY2022	curr	Weighted Average Discount Rate In Percentage WeightedAverageDiscountRateInPercentage	0.1130	pure
CY2022Q4	curr	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	124000	usd
CY2022Q4	curr	Long Term Portion Of Operating Lease Liability LongTermPortionOfOperatingLeaseLiability	46000	usd
CY2022	curr	Schedule Of Future Lease Paymentstabletextblock ScheduleOfFutureLeasePaymentstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Undiscounted cash flow</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">184</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effects of discounting</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(14 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lease liabilities recognized</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">170</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	138000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	46000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	0	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	0	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	0	usd
CY2022Q4	curr	Lessor Operating Lease Payments Undiscounted Cash Flow LessorOperatingLeasePaymentsUndiscountedCashFlow	184000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	14000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	170000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	257000	usd
CY2022Q4	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	124000	usd
CY2021Q4	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	104000	usd
CY2022Q4	curr	Right Of Use Lease Liability Noncurrent RightOfUseLeaseLiabilityNoncurrent	46000	usd
CY2021Q4	curr	Right Of Use Lease Liability Noncurrent RightOfUseLeaseLiabilityNoncurrent	174000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	170000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	278000	usd
CY2022	curr	Weighted Average Remaining Lease Term Operating Lease WeightedAverageRemainingLeaseTermOperatingLease	P1Y3M14D
CY2021	curr	Weighted Average Remaining Lease Term Operating Lease WeightedAverageRemainingLeaseTermOperatingLease	P2Y3M14D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.113	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.113	pure
CY2019	curr	Lease Monthly Payment LeaseMonthlyPayment	1	usd
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	62000	usd
CY2019Q4	curr	Lessee Finance Lease Liability LesseeFinanceLeaseLiability	62000	usd
CY2020Q4	us-gaap	Cash Cash	1000000.0	usd
CY2022	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	5988024	shares
CY2020Q4	curr	Fair Value Of The Contingent Shares Amount FairValueOfTheContingentSharesAmount	3200000	usd
CY2020Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	3205000	usd
CY2021	curr	Change In Fair Value Of Contingent Stocks Consideration ChangeInFairValueOfContingentStocksConsideration	-1775000	usd
CY2021Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	1430000	usd
CY2022	curr	Change In Fair Value Of Contingent Stocks Consideration ChangeInFairValueOfContingentStocksConsideration	-570000	usd
CY2022Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	860000	usd
CY2022Q3	curr	Consideration Paid For Asset Sale ConsiderationPaidForAssetSale	20000000.0	usd
CY2022Q3	curr	Cancellation Of Indebtedness Owed By The Company To Buyer In Amount Equal CancellationOfIndebtednessOwedByTheCompanyToBuyerInAmountEqual	41500	usd
CY2022Q3	curr	Cash Reduced By Assumed Liabilities CashReducedByAssumedLiabilities	41000	usd
CY2022Q3	curr	Retained Other Patents Not Included In The Asset Sale RetainedOtherPatentsNotIncludedInTheAssetSale	15	integer
CY2022Q3	curr	Net Cash Received From The Asset Sales Price NetCashReceivedFromTheAssetSalesPrice	20000000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Forgiveness Of Buyer Advances NetCashReceivedFromTheAssetSalesForgivenessOfBuyerAdvances	-4150000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Holdback Secured Promissory Note NetCashReceivedFromTheAssetSalesHoldbackSecuredPromissoryNote	-2000000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Obligations Assumed By Buyer NetCashReceivedFromTheAssetSalesObligationsAssumedByBuyer	-41000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Buyers Expense To Be Paid By Seller NetCashReceivedFromTheAssetSalesBuyersExpenseToBePaidBySeller	82000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales NetCashReceivedFromTheAssetSales	13891000	usd
CY2022Q3	curr	Sales Price For Assets Sold SalesPriceForAssetsSold	20000000	usd
CY2022Q3	curr	Net Book Value Of Assets Sold NetBookValueOfAssetsSold	20616000	usd
CY2022Q3	curr	Net Book Value Of Liabilities Sold NetBookValueOfLiabilitiesSold	-51000	usd
CY2022Q3	curr	Net Book Value Of Net Assets Sold NetBookValueOfNetAssetsSold	20565000	usd
CY2022Q3	curr	Gain Loss On Sale Of Net Assets GainLossOnSaleOfNetAssets	-565000	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	20600000	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	4000000.0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities	3400000	usd
	curr	Consideration To Be Received From The Buyer ConsiderationToBeReceivedFromTheBuyer	20000000.0	usd
	curr	Additional Impairment Loss AdditionalImpairmentLoss	2000000.0	usd
CY2022Q2	curr	Estimated Costs To Sell Charged To Goodwill EstimatedCostsToSellChargedToGoodwill	100000	usd
CY2021Q4	curr	Inventory Net Assets Held For Sale InventoryNetAssetsHeldForSale	243000	usd
CY2021Q4	curr	Prepaid Expense And Other Assets Current Assets Held For Sale PrepaidExpenseAndOtherAssetsCurrentAssetsHeldForSale	97000	usd
CY2021Q4	curr	Property Plant And Equipment Net Assets Held For Sale PropertyPlantAndEquipmentNetAssetsHeldForSale	1837000	usd
CY2021Q4	curr	Finance Lease Right Of Use Asset Assets Held For Sale FinanceLeaseRightOfUseAssetAssetsHeldForSale	40000	usd
CY2021Q4	curr	Goodwill Assets Held For Sale GoodwillAssetsHeldForSale	9178000	usd
CY2021Q4	curr	Intangible Assets Net Excluding Goodwill Assets Held For Sale IntangibleAssetsNetExcludingGoodwillAssetsHeldForSale	14401000	usd
CY2021Q4	curr	In Process Research And Development Net InProcessResearchAndDevelopmentNet	329000	usd
CY2021Q4	curr	Other Assets Assets Held For Sale OtherAssetsAssetsHeldForSale	35000	usd
CY2021Q4	curr	Total Assets Classified As Assets Held For Sale TotalAssetsClassifiedAsAssetsHeldForSale	26160000	usd
CY2021Q4	curr	Accrued Utilities Current Assets Held For Sale AccruedUtilitiesCurrentAssetsHeldForSale	268000	usd
CY2021Q4	curr	Finance Lease Liability Current Assets Held For Sale FinanceLeaseLiabilityCurrentAssetsHeldForSale	40000	usd
CY2021Q4	curr	Deposit Contracts Liabilities Assets Held For Sale DepositContractsLiabilitiesAssetsHeldForSale	215000	usd
CY2021Q4	curr	Total Liabilities Classified As Liabilities Held For Sale TotalLiabilitiesClassifiedAsLiabilitiesHeldForSale	523000	usd
CY2022	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	108000	usd
CY2021	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	351000	usd
CY2022	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	58000	usd
CY2021	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	52000	usd
CY2022	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	40000	usd
CY2021	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	74000	usd
CY2022	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	206000	usd
CY2021	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	477000	usd
CY2022	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	75000	usd
CY2021	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	424000	usd
CY2022	curr	Gross Profit Loss GrossProfitLoss	131000	usd
CY2021	curr	Gross Profit Loss GrossProfitLoss	53000	usd
CY2022	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	487000	usd
CY2021	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	2371000	usd
CY2022	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	526000	usd
CY2021	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	1155000	usd
CY2022	curr	Depreciation And Amortization Assets Held For Sale DepreciationAndAmortizationAssetsHeldForSale	794000	usd
CY2021	curr	Depreciation And Amortization Assets Held For Sale DepreciationAndAmortizationAssetsHeldForSale	1141000	usd
CY2022	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	4728000	usd
CY2021	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
CY2022	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	6535000	usd
CY2021	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	4667000	usd
CY2022	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-6404000	usd
CY2021	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-4614000	usd
CY2022	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2021	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2022	curr	Net Loss NetLoss	-6404000	usd
CY2021	curr	Net Loss NetLoss	-4614000	usd

Files In Submission

Name	View Source	Status
0001477932-23-005602-index-headers.html	Edgar Link	pending
0001477932-23-005602-index.html	Edgar Link	pending
0001477932-23-005602.txt	Edgar Link	pending
0001477932-23-005602-xbrl.zip	Edgar Link	pending
curr-20221231.xsd	Edgar Link	pending
curr_10k.htm	Edgar Link	pending
curr_ex211.htm	Edgar Link	pending
curr_ex311.htm	Edgar Link	pending
curr_ex312.htm	Edgar Link	pending
curr_ex321.htm	Edgar Link	pending
curr_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
curr-20221231_def.xml	Edgar Link	unprocessable
curr-20221231_lab.xml	Edgar Link	unprocessable
curr-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
curr_10k_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
curr-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

2022 Q4 Form 10-K Financial Statement

#000147793223005602 Filed on July 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW Avenir Wellness Solutions, Inc. Stock $avrw

2022 Q4 Form 10-K Financial Statement

#000147793223005602 Filed on July 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw